INSP
Inspire Medical Systems, Inc.
NYSE · Healthcare · Medical - Devices · US
$63.08
+1.51%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
49.6x
EV/EBITDA
18.4x
Market Cap
$1.82B
MomentumView details →
1D Return
+1.51%
YTD Return
−31.62%
RSI (14)
62.0
ValuationView details →
P/E (Fwd)
49.6x
EV/EBITDA
18.4x
Market Cap
$1.82B
RSI (14)
62.0
MomentumView details →
1D Return
+1.51%
YTD Return
−31.62%
SummaryUpdated Jun 1, 2026
Inspire Medical Systems, Inc. (NYSE:INSP) is a medical technology company founded in 2007 and headquartered in Golden Valley, Minnesota. The company went public in May 2018 and has established itself as a pioneer in neurostimulation therapy for obstructive sleep apnea (OSA). Since its founding, Inspire has grown from a development-stage company to a profitable enterprise that has treated over 100,000 patients worldwide. The company achieved its first full year of profitability in 2024, marking a significant milestone in its commercial journey.
Similar companies
Latest newsMore news →
Bank of America Corp DE reduced its stake in Inspire Medical Systems, Inc. by 11.4% during the quarter, selling 24,057 shares, according to its 13F filing.11d agoInspire Medical Systems reported second quarter 2026 financial results with revenue of $200.6 million, diluted EPS of $0.01, adjusted diluted EPS of $0.14, and operating cash flow of $23.2 million, and raised its 2026 guidance and announced a strategic growth plan to redeploy $30 million for growth initiatives.32d ago